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Summary.-An attempt has been made to construct an assay potentially suitable
for use with primary cultures of human tumours to measure the survival of expo-
nentially growing monolayer cultures after exposure to anti-neoplastic drugs.
Cell survival was assessed using their protein synthetic capacity after removal
of drugs. HeLa cells were employed to avoid the inherent variability and hetero-
geneity of primary cultures from human tumours, and an assay has been constructed
using microtitration trays to provide large numbers of replicate cultures without
the requirement of a large number of cells. An increase in the duration of the
exposure to drug increased sensitivity in nearly all cases examined. Similarly,
an increase in the period of culture following drug removal produced increased
sensitivity to alkylating agents but allowed recovery from exposure to certain
cycle-dependent drugs.
Some of the drugs used were shown to be unstable under culture conditions
and vinblastine was actively metabolized, although this instability was not neces-
sarily reflected in the time course of the drug's effect. Mustine sensitivity was
shown to be reduced by an increase in cell density at a level where density limitation
of 3H-thymidine incorporation becomes apparent.
These variations and possible methods of minimizing their effects are discussed.
CYTOTOXICITY of anti-neoplastic drugs
in vitro has been used to assess their
likely relative potencies in clinical treat-
ment (Limburg and Heckman, 1968;
Jzsak et al., 1971), and in animal experi-
ments (Morasca et al., 1972; Ogawa,
Bergsagel and McCulloch, 1973). There
are numerous possible sources of error in
this type ofscreening, including variations
in the proportions of different cell types
in tissue samples and difficulty in the
selection of assay conditions which will
give an accurate indication of the sensi-
tivity of the cells to the drugs tested.
The relative in vitro colony forming
ability of treated and untreated cell
samples is the most commonly used
method of assessing drug sensitivity.
Although this method has considerable
advantages, it is not readily applied to
primary cultures of human tumours due
to their very low cloning efficiency and
the slow growth rate of the clones.
The adoption of an assay using mono-
layer cultures, based on their proliferation
ability alone, requires extensive cell count-
ing and would become extremely un-
wieldy where large numbers of samples
are used. The metabolic inhibition test,
as used in virus assay (Rosenthal and
Shechmeister, 1973) is quicker and capable
ofhandling very large numbers ofsamples.
The major difference in this type of test
is that metabolic activity is measured
rather than proliferation. Protein syn-
thesis was selected in this case as a
fundamental metabolic process without
which the cell will not survive. 3H-R. I. FRESHNEY, J. PAUL AND I. M. KANE
leticine incorporation was used as an
index of protein synthesis. As leucine is
an essential amino acid, it is unlikely
that protein synthesis could continue for
long, unimpaired, without leucine incor-
poration. Hence the absence of protein
synthesis, particularly several hours after
removal of drug, will almost certainly
correlate with cell death.
The relative importance of technical
aspects of the assay procedure was
suggested by some variations in prelimin-
ary results with cultures from human
tumour biopsies (Freshney and Paul,
1974). Because of the relatively slow
growth rates and heterogeneity of such
cultures, we have undertaken the follow-
ing experiments with HeLa cells in ani
attempt to identify the most likely
sources of variation affecting the validity
of this type of assay.
MATERIALS ANI) METHODS
(Cell culture. HeLa-CS and HeLa-S83 (Fig.
5 onily) cells (Flow Laboratories, Irvine)
were grown in Ham's F12 medium supple-
nented uwith Eagle's MEM amino acids (Flow
Laboratories, Irvine), 20% foetal bovine
serum (Biocult Laboratories, Paisley) and
50 u/ml benzylpenicillin. Although more
than adequate for HeLa cells, this medium
was selected to be consistent wNith parallel
experiments with primary tumour cultures
which require a highly enriched medium.
Drug sensitivity experimients. -The follow-
ing procedure was used for all experiments
with individual modifications as noted in
the figure legends: Monolayer cultures were
trypsinized and transferred to microtitre
trays (Flowr Laboratories), each tray having
8 horizontal row s of 12 wells. After 1-3
days, drugs wNere added to the extreme left-
hand wells and serially diluted across tihe
plate. Tile last 2 wells in each rowr uwere
left, free of drug to act as controls. After
24 h the drug solutions were removed by
suction, the monolayer washed with Hanlks'
balanced salt solution (BSS) and fresh
growth medium added for a further 4-24 h.
'T'his -was then replaced with growtlh medium
containing, 5 uCi/ml L-leucine-4, 5-3H (10
,uCi/ptmnol final specific activity) (Radiochemiii-
cal Centre, Amershamn) and incubation con-
tinned for a further 4-24 h. W\rheni thie
length of the labelling period wNas varied
it wA,as showAn that the incorporation of 3H
leucine increased propoi'tionally wAitlh time
over 2-20 h. The plates Awere then wzaslhed
in BSS, fixed in methanol and dried. Acid-
soluble precursors wNere extracted with twTo
10-min wAashes of ice-cold (06 mol/1 trichloro-
acetic acid, the trichlioroacetic acid washed
off with cold distilled wNater and the residual
cellular material dissolved in 1 N NaaOH.
The samples wAere acidified with excess
1*1 N HCl and the radioactivityv deterrninied
by scintillation counting.
The drugs used were as in Table 1.
Presendtation of dlata. W0theni tlle 3H-
leucine incorporation per well is plotted
against the drug conceintration a sigmoid
curve is obtained, the typical form of which
is represent,ed diagrammatically in Fig. 1.
In most cases wN-here the bottomn enid of the
curve flattens out, 3H-leucine incorporation
is close to the background for the assay
(10-20 ct/min per wN-ell). The maximum
inhibition (Imax), and the drug concentration
at 500() inhibition (ID50) mayl be determined
from the curve. The ID50 values are then
available for plotting against a third variable
such as cell density, time of exposure to
drug etc.
In later experiments, the dlerivation of
these values has been automiated usinlg a
punched tape output firom the scinitillationi
counter and analysing the tape on a Wang
desk-top computer. The author-s ale in-
debted to Dr Bryani Youing of this Inistituite
f'or the provision of a progralnme for this
operation.
RESULTS
Stability and mietabolismii of dra,ys diarii y
incubation
To test for dlegradatioin of cIruigs
4 microtitre plates were set up, 2 contain-
ing cells at 5 x 103/well (5 x 104/ml)
and Ino drugs (assay plates), one coIn-
taining serial diluitions of 5 drugs but ino
cells (drug preincubation plate), aind one
containing medium only (medium pre-
incubation plate). After 24 h the meditum
from one assay plate wvas discarded andI
replaced with thle medium from the drtug
preincubation plate. The medium from
the secon(l assay plate wN-as removed and(l
replaced with mnediutmn from the meedium
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TABLE I
Drug
Chlorambucil
AMustine HCl
Triethylene
thiophosphoramide
Cyclophosphamide
6-Mercaptopurine
Methotrexate
6-Thioguanine
Vinblastine SO4
Presumed
action
Alkylating
Alkylating
Alkylating
Alkylating
Anti-metabolite
Anti-metabolite
Base analogue
Anti-mitotic
Abbre- Trade
viation name
CB Leukeran
MU Mustine
TT Thiotepa
CY Endoxana
MP Puri-methol
MT Methotrexate
TG
VB Velbe
Supplier
Burroughs Wellcome
Boots
Lederle
W.B.P.
Burroughs Wellcome
Lederle
Sigma
Lilly
Highest conc. used
..
mg/ml mmol/l
3-33 11 0
3-33 17-3
1-33 7 07
6 67 25-5
3-33 21-9
1*67 3-67
0 333 2*00
0 167 0 205
le
103
U9
10
.1
In
ID o
I 7, _ io 10
0 10-3 1o-2 10-1 10° 10' 2 103
,pMolority of drug
Fio. 1.-Diagrammatic representation of typical inhibition curve. The " control " is the counts
from the untreated end of the microtitre plate and the curve represents the decline in counts from
incorporated 3H-leucine with increasing drug concentration. The intercept on the horizontal
axis of the value equivalent to 50 % inhibition is taken as the ID50.
preincubation plate; fresh drugs were
added to this and were diluted serially
across the plate (controls).
Comparison of the ID50s of drugs
with and without preincubation (Table II,
Exp. 1) showed that preincubation had
produced a reduction in cytotoxicity,
implying that the effective concentration
of drug had diminished. The difference
in the ID50s was greatest with mustine,
about 25-fold, while with chlorambucil
it was about 6-fold and with cyclo-
phosphamide about 3-5-fold. The change
in the ID50 for thiotepa was only about
40%, and vinblastine showed no reduc-
tion in cytotoxicity at all.
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rrABLE II. Effect ofPreincubation ofDruas on ID50s
E.tpt 1
Cells abseIIt ( tirinig prinlclat iatOll
Drug
YB
TT
MIU
CY
CB
Drtugs preinCubated
(y2mol/l)
(t '9~4h
9-27 x 10-5
158
66-4
2940
334
8-32x 10-5
218
1730
8620
2130
Preincubat,ed Ratio - Control
0 90
1*38
26 - 1
3-46
6-38
E.Vpt 2
Cells prlesSet (utirinig lpeinic sbation
It is also possible that duiring drug
exposure some mnetabolism of the drugs by
the cells may occur. To test this, the
same experiment was repeated with HeLa-
C8S cells present in the preincubation
plates at a higher density (105 cells/well)
than in the assay plates (5 5 x i 03/well)
to accentuate metabolism of the (Irugs.
After 24 h the preincubation plates were
frozen and thawed 3 times to release
soluble intracellular drug, and the medium
was transferred to the assay plates.
Fresh Irtigs were added to the plate
receiving preincuibated mediuim only; both
were inctubated for a further 24 h and(
the ID50 determined as before. It can
be seen from Table II (Exp. 2) that the
ID50 ofthiotepa and chlorambucil changed
bv about the same amount in each
experiment while that of cyclophospha-
mide decreased slightly. The increase
in the ID50 for mustine wrxas less when
cells were presenit during preincubation,
implying a protective effect of the cells,
perhaps bv intracellular biniding. AYin-
blastine, however, showed a marked in-
crease in the ID50 (about 2 x 104 fold),
suggesting that, while it may be stable
in the mediuim alone, it is degraded in
the presence of HeLa cells. This marked
depletion in the vinblastine effect could
also be explainied by irreversible binding
of the drug to the preincubationi mono-
la-er. However, sinice the effect of vin-
blastine is reversible (see below) this
explanation seems less likelv.
Time of exposure to drug
In this experiment, 4 plates were set
up at 5 x 103 cells/well and grown for
24 h. Drugs were then added to each
plate and removed at times ranging from
2 to 24 h. The plates were washed in
BSS, allowed to recover for 22 h, and
labelled with 311-leucine. The incorpora-
tion was plotted against drug concentra-
tioin, and the ID50s calculated. The plot
of the ID50s against exposure time is
presented in Fig. 2. Treatment for 2 or
4 h was insufficient to cause 5000 inhibi-
tion with cvclophosphamide or thiotepa.
Vinblastine and mercaptopurine both
showed an exponential decrease in ID50
with time of exposure. The decreases
in the ID50s for mustine and chlorambucil
are not continuously exponential; chlor-
ambucil showed no change in ID50
between 0 and 22 h.
It has been demonstrated that the
inhibitory effects of methotrexate on
DNA synthesis (Hussa and Pattillo, 1970)
and the cytotoxicity of 6-mercaptopurine
(Tidd et al., 1.972) are not evident until
after several days' exposure. In order
to provide this extended exposure, but
at the same time to maintain effective
concentrations of those drugs which had
been shown to be unstable, 4 identical
YrB
TT
AIU
CY
Cl13
10-5 4-64,
216
57 -1
5)280
59.7
0-93
276
779
3010
4390
2 x 1()4
1 -28
13-6
0-57
7.35
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FIG. 2. Effect of time of incuibation wvith
drtugs from 2 to 20 h. Fouir plates wer-e set
up at 5 x 1(4 cells/ml (5 x 103/wVell) ain(d
iinecubated( for 24 h befoie a(l(ding (Irugs.
Aftet the times indicated(, the cells were
washed( free ofclrugs an(l allowed to recover
for 22 h. They were theni labelledl with 2(0
y1Ci/ml (4(0 /iCi/Imol) 3H1l-eucine for 2') h,
washed an(l the pr otein extracte(l an(d
counte(l. The ID50 for each dlrtug at each
time of exposure was dleteimined as des-
cribe(d in the rnetho(ds, ani(l the valtues are
plotted( semi-log against time.
plates were set up and treated with drugs
over 7 days, with replacement with fresh
drugs after 1, 2 and 3 days. Twenty-
four houirs after removal of drugs each
plate was labelled with 3H-leucine as
before and the ID50s calculated. The
data are presented in Fig. 3.
It is apparent that the ID50s became
progressively less the longer the exposure
time. This applied to all the drugs but
was more marked with some than others.
It was particularly striking with metho-
trexate where there was a decrease in
the ID50 of about 15-fold between one
and 3 days exposure and of nearly 6
orders of magnitude by 7 days. It
should be noted that since the first 3
applications of drugs were of 24 h each
and the final application lasted 3 days,
there is a break in the horizontal axis
to allow for this discontinuity.
Duration of culture after removal of drugs
As the aim ofthe assay was to estimate
residual viability after drug treatment
rather than to determine the immediate
effect of cytostatic drugs on protein
synthesis, it was considered important
to allow the immediate effects to wear off,
i.e. to wash out the drug and allow
surviving cells to recover.
The effect of varying the length of
the recovery period on the estimated
ID50 was examined. After removing the
drugs, fresh medium was added and
changed every 3 days. Samples were
taken at 0, 1, 2, 5 and 9 days after
removal of the drugs. A continuous
decrease in the ID50 was observed for
chlorambucil, thiotepa and mustine over
the first 5 days (Fig. 4a). Thereafter
these drugs showed no further decreases.
The ID50s of mercaptopurine, thioguanine
and vinblastine increased rapidly (vin-
blastine by 8 orders of magnitude) (Fig.
4b), implying reversal of the cytotoxic
action of the drugs or overgrowth of less
sensitive cells.
The data from methotrexate are dif-
ferent from the patterns exhibited by the
other drugs, showing partial recovery of
protein synthesis between 24 and 48 h
after removal of the druigs, followed by a
rapid fall after 5 days.
C(ell density and drgu sensitivity
During preliminary investigations of
the drug sensitivity of primary cell
strains from human tumour biopsies,
large differences in ID50 were detected
which could be attributed to changes in
cell density (Freshney and Paul, 1974).
To examine the effect of varying the
cell density on the cytotoxicity ofmustine,
ID50s were determined in a range of
densities from 2 x 104 cells/mm2 down
to 200 cells/mm 2. The plot of ID50
against cell density (Fig. 5) shows that
0
MP
CB
0 TT
U~~M
VB
I I I I~~~~~~~~~~~~~~~~~~~~~~~~
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2 3 7
Drug exposure (Days)
2 3 7
Fie. 3.- Prolonged drug exposure. Four plates were set up at 104 cells/mi (2 x 103/Well) and
grown for 3 days before addition of dtrugs. At 24, 48 and 72 h one plate was harvested and the
(lrugs replenished in the remaining plates. The final plate was left for 4 days in the last applica-
tion of (Irtugs. After removal of drugs, the cells were allowed to recover for 22 h and were then
labelled for 4 h with 5 1,Ci/ml 3H-leucine (10 ,uCi/,umol). The cell protein was then extracted
and counted as before, the ID5O calculated and plotted, semi-log against time of exposure to
(Irug. Since the fourth exposure lasted 4 days and many of the drugs would either be degraded
or metabolized within this time, the actual length of this time of exposure is difficult to assess
so there is a break in the time axis at this point. Since the minimum value for the ID50 for
methotrexate is off the or(linate scale the actual valuie is given in parenthesis beloNv the point.
Abbreviations as in Table I.
the ID50 remained relatively constant
over a range of cell densities from around
200/mm2 up to 5 X 103/mm2. Above
this level there was a marked increase in
ID50 (decrease in sensitivity). The in-
crease in ID50 above 5000 cells/mm2
was correlated with a reduction in the
rate of If3-thymidine incorporation. There
was, however, no change in the ID50 at
the lowest cell density where a reduction
in 3H-thymidine incorporation was also
observed.
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(b) VB
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Days after drug r e mova
FiG. 4.-Effect of prolonging the culture period after removal of drugs. Five plates were set up
at 5 x 104 cells/ml (104/well) and grown for 24 h. Drugs were then added for 24 h, after which
one plate was labelled (as in Fig. 3) and the remainder maintained in culture for a further 1, 2, 5
and 9 days, before labelling. After labelling the cells were washed, the protein extracted and
counted and the ID50S calculated. They are plotted semi-log against time. In (b) the left-
hand vertical axis refers to MP, TG and MT and the right hand to VB. Abbreviations as in
Table I.
DISCUSSION
The object of this work has been
to study some of the potential variations
to which in vitro assays are subject
and, perhaps, to indicate ways of mini-
mizing these variations.
One of the problems of any drug
sensitivity measurement is that of altera-
tion of the drug, by metabolism or
7
degradation. Some drugs, e.g. mustine
and chlorambucil, were shown to be
unstable whereas thiotepa was not. Vin-
blastine, though stable in the medium,
was actively metabolized in the presence
of HeLa cells. When these findings are
compared with the changes in ID50 with
time of exposure to drugs, it can be
observed that the two unstable drugs,
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FIG. 5.-Effect of cell (lensity on ID50 of mustine. Two plates were set up with a range of cell
concentrations in each from 106 cells/ml (105/well) in the first horizontal row, 5 x 105/ml
(5 x 104/well) in the second horizontal row and so on by 2-fold dilutions to 7800 cells/ml (780/well).
After 3 days mustine was added to all the rows on one plate and left for 24 h. The cells in the
first 3 vertical rows of the second plate were counted on a Coulter Model D. 'H-thymidiie
1 uCi/ml (22 mCi/Mmol) was added to the next 3 vertical rows for 24 h, after which the cells were
washed in Hanks' BSS, the acid soluble precursor pool extractedl into 0-6 mol/l trichloroacetic
acids, and the DNA hydrolysed into 2 N perchloric acid at 60°C. The hydrolysate was counte(1
directly in Triton X/toluene based scintillator.
After 24 h exposure mustine was removed and the cells allowed to recover for 4 h. They
were then labelled overnight (18 h) with 10 SiCi/ml 3H-leucine, processed as in Fig. 2 and the ID50s
calculated.
The data are presented as a double log plot of (i) ID50 in ,umol/litre (open circles) and (ii)
incorporation of 3H-thymidine per 103 cells (closed circles) against cell (tensity (cells/mm2) derived
from Coulter cell count obtained on the day of drug addition.
mustine and chlorambucil, did not give
a continuous increase in sensitivity with
time of exposure as might have been
predicted. Vinblastine, however, which
has been shown to be actively metabolized,
did show a continued exponential in-
crease. Hence, the stability of these
drugs as determined by the residual
activity in the medium cannot always be
used to predict the duration of their
intracellular effect. It should be noted
here that this method of demonstrating
instability does not take account of
binding of drug to the walls of the culture
vessel. Since some drugs show increasing
effects between 12 and 24 h and others
do not, the length of drug exposure can
influence the interpretation of the relative
drug sensitiveness.
The shape of the curves in Fig. 2
could also be explained by assuming
that the effects of mustine and chlor-
ambucil are complete by 6-8 h. How-
ever, as indicated previously by Fox et
al. (1970) for methyl methanesulphonate,
subsequent repeated applications of the
drugs gives continuously decreasing ID50s.
This suggests that cytotoxicity is not
0
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complete by 8 or even 24 h exposure.
Wtere the drug exposure limited to 8 h,
then the ID50s of drugs such as 6-mercap-
topurine and methotrexate, which have
little effect even after 24 h, would be
difficult or even impossible to measure
in this type of assay. It has been shown
here, however, that the reduction in
ID50s obtainable by repeated applications
makes measurement possible for all the
drugs and at concentrations where solu-
bility problems are minimal.
Since the interpretation of these and
subsequent results may be influenced by
the method of measuring viability, it is
necessary to define what is meant by
" viability " and " survival ". It is as-
sumed that the criterion used, 3H-leucine
incorporation into acid insoluble material,
will approximately reflect the amount
of protein synthesis per well. Hence,
zero inicorporation of 3H-leucine clearly
means zero viability and it is assumed
that 3H-leucine incorporation equal to
the untreated control means maximum
viability (usually 100% in HeLa cells
by dye exclusion, but may be lower in
primary cultures). Hence, "viability "
and " survival " have their literal meaning
and do not imply proliferation.
During the course of the shorter
assay, using 24 h drtug exposure, 4 h
recovery and 4 h labelling period, pro-
liferation following drug exposure will
be minimal unless cells of a very short
(say 12 h) cell cycle are used, and inhibi-
tion of 3H-leucine incorporation may
represent both reduced protein synthesis
per cell and a reduced cell number.
As the recovery period is extended, the
difference between control and treated
cells will become greater, due to unlimited
proliferation in the controls, until the
magnitude of the difference may be
50-100 times (per 5 cell cycles recovery
and a 24 h cell cycle). Hence the majority
of the inhibition of incorporation in
treated wells will now represent inhibi-
tion of proliferation rather than inhibition
of synthesis per se.
Although all the graphs in Fig. 3
imply a cumulative effect of the drugs
with increasing exposure time, the reasons
may differ among drugs. While repeated
application of alkylating agents may
simply increase the amount incorporated,
repeatedexposures to the cycle dependent
drugs will exposure fractions of the
population previously resistant, due to
their position in the cell cycle. However,
the change in response to cycle dependent
drugs with increasing time should diminish
after the time required for the whole
population to go through the cell cycle.
Since this is not so, it must be assumed
that a dosing effect, similar to the
alkylating agents, is in operation and for
each successive treatment more analogue
is incorporated and cytotoxicity increases.
Extended drug exposure may also
influence the cytotoxicity of drugs such
as cyclophosphamide, which require to
be metabolized (Dolfini et al., 1973;
Sladek, 1973). In the present experi-
ments cyclophosphamide, which has a
very high ID50 after 24 h exposure, shows
relatively little increase in cytotoxicity
with increased exposure time. This rate
of increase in cytotoxicity is less than
with any other alkylating agent and may
imply that HeLa cells do not oxidize
cyclophosphamide so efficiently. Prein-
ctubation of cyclophosphamide with HeLa
cells before use did give a reduced ID50
(Table II) but only by about 40%o.
This suggests that the in vitro assessment
of cyclophosphamide sensitivity may be
inaccurate unless the drug is activated.
Although the effect of the alkylating
agents appears to be irreversible, and
prolonged culture after their removal
increases their apparent cytotoxicity, the
toxic effect of anti-metabolites such as
6-mercaptopurine and thioguanine shows
apparent reversal. It is not possible to
distinguish in this assay between reversi-
bility at the biochemical level and over-
growth by resistant cells. The effect of
either is to cause an increase in 3H-leucine
incorporation per well, relative to the
control, which tends to shift the ID50
to a higher drug concentration. Since
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the anti-metabolic activity of 6-mercapto-
purine is mediated via competitive enzyme
inhibition, muLch of its effect would be
expected to be reversible and this may
be the case. Although a component of
the cytotoxicity ofthioguanine may result
from its inicorporation as a base analogue
into DNA (Alexander, Connors and Mar-
baix, 1971) and wotuld be irreversible,
some of the cytotoxicity reported here
may result from incorporation into RNA
(Alexander et al., 1971) and may be
reversible.
Since the action of Vinca alkaloids at
relatively o0W concentrations is phase-
specific, the reversal ofvinblastine activity
may be produced partly by overgrowth
of cells in a resistant phase of the cycle
during exposure. The action of vin-
blastine is also freely reversible (Connors,
1971) and this may explain the very
rapid rate of recovery after its removal.
Methotrexate acts as a competitive in-
hibitor of folate-reductase activitv. The
affinity of the inhibitor for the folate-
reductase enzymes is so high that its
effect is generally thought to be irre-
versible. However, some reversal of
mnethotrexate toxicity was observed over
the first 48 h after removal of the drug.
The primary result of methotrexate treat-
ment appears to be a cessation of DNA
synthesis and a reduction in RNA and
proteiii synthesis follows later. This
wouldl explain the delayed induction of
cytotoxicity apparent by 4 days but not
the initial recovery over the first 2 days.
The reasons for this are not clear.
The duration of the assay may there-
fore profoundlv affect the interpretation
of results. Some of the reasons for this
can easily be identified. They can be
summarized as follows: (i) changes in
effective drug concentration by meta-
bolism and spontaneous decay; (ii) dif-
ferences in rates of incorporation of
druigs; (iii) delay between inhibition of
the metabolic pathways affected by the
druig and inhibition of the parameter
measured in the assay (in this instance,
protein synthesis); (iv) the number of
mitotic cycles undergone dturing exposure;
(v) growth of relatively resistant cells;
this relates frequently to the cycle de-
pendent nature of the drug's action.
(It can be seen from Fig. 4 that those
drugs which show reversal of cytotoxicity
are those that are cycle dependent); (vi)
attainment of confluence and density lim-
ited conditions during or after exposure.
In addition to the effects of a change
in cell density during the assay, the
initial cell density at the time of drug
ad(ldition will also affect the resuilts. As
can be seen from Fig. 5, cells which are
already in a density limited state may be
much less sensitive to certain drugs.
This may be correlated directly with the
rate of DNA synthesis, as suiggested in
Fig. 5, or may be duie to differences in
membrane permeability (Goldeniberg et
al., 1971). The observation that mutstine
degradation does not increase in the
presence of a high cell concentration
(see above) suggests that metabolism of
the drug is not a major influence on the
ID50. In spite of the fact that the
culture medium was replaced daily, the
possibility of a gradually increasing pro-
portion of cells of low viability produced
by overcrowding cannot be discouinted.
It is important that some account
be taken of the variation described above
in aniy attempt to use in vitro assay for
predictive drug screening. It may, in
fact, be difficult to devise a standard
techniique for all cytotoxic agents but
the most satisfactory compromise may
be to design the test system such that
(1) exposure to drug covers at least 2 cell
cycles, (2) conditions are selected such
that control cultures maintain logarithmic
growth throughout the assay and (3)
sufficient time is allowed for (lelayed
cytotoxicity to be expressed.
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